Immunic earnings were -$100.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IMUX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$25.2M, up 3.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMUX reported annual earnings of -$100.5M, with 7.4% growth. The next IMUX earnings date is Jun 11, 2025.
Immunic (NASDAQ: IMUX) reported Q4 2024 earnings per share (EPS) of -$0.25, up 84.38% year over year. Total IMUX earnings for the quarter were -$25.18 million. In the same quarter last year, Immunic's earnings per share (EPS) was -$1.60.
The next IMUX earnings call is Invalid Date. Add IMUX to your watchlist to be reminded of Immunic's next earnings date.
What was IMUX's earnings growth in the past year?
As of Immunic's earnings date in Q2 2025, Immunic's earnings has grown year over year. IMUX earnings in the past year totalled -$100.51 million.
Is Immunic profitable or losing money?
As of the last Immunic earnings report, Immunic is currently losing money. Immunic's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$100.51 million, a 7.37% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.